Related Experiment Videos
Effects of progabide on bicuculline-induced epileptic seizures in developing rats
O Mecarelli1, M R de Feo, M F Rina
1Dipartimento di Scienze Neurologiche, Università La Sapienza, Rome, Italy.
Insights
Progabide, a gamma-aminobutyric acid (GABA) receptor agonist, shows limited effectiveness against seizures in young rats due to immature GABAergic systems. Pretreatment with progabide offers better protection in developing rats, with effectiveness increasing with age.
Area of Science:
- Neuroscience
- Pharmacology
- Developmental Biology
Background:
- The GABAergic system plays a crucial role in regulating neuronal excitability and is implicated in epilepsy.
- Understanding the developmental trajectory of the GABAergic system is essential for evaluating the efficacy of GABAergic drugs in young populations.
Purpose of the Study:
- To investigate the antiepileptic effects of progabide, a direct GABA receptor agonist, in developing rats.
- To correlate the drug's effectiveness with the maturation of the GABAergic system in early life stages.
Main Methods:
- Bicuculline-induced seizures were modeled in rats aged 7-28 days.
- Progabide was administered via single injection (treatment) or repeated daily administrations (pretreatment).
- Seizure incidence, latency, behavioral characteristics, evolution to status epilepticus, and recovery rates were evaluated.
Main Results:
- Progabide treatment was largely ineffective in 7-14-day-old rats, likely due to immature GABAergic systems.
- Pretreatment with progabide showed a more significant anticonvulsant effect in younger rats, especially at higher doses.
- In 15-28-day-old rats, progabide treatment reduced mortality from status epilepticus but did not significantly alter seizure parameters; pretreatment remained more effective.
Conclusions:
- The antiepileptic efficacy of progabide is age-dependent, correlating with the functional maturation of the GABAergic system.
- Pretreatment strategies with progabide may be more beneficial than single-dose treatment in developing rodents.
- Further research into developmental neuropharmacology is warranted for optimizing epilepsy treatment in pediatric populations.
Abstract:
The effects of progabide, a direct gamma-aminobutyric acid (GABA) receptor agonist, on bicuculline-induced seizures have been tested in developing rats, ages 7-28 days, to study the correlation between the antiepileptic effectiveness of this drug and the level of functional maturation of the GABAergic system. The incidence, latency of appearance, and behavioral characteristics of the epileptic manifestations, their evolution toward status epilepticus, and the percentage of recovery from status epilepticus have been evaluated in rats that had received a single injection (treatment) or three successive daily administrations (pretreatment) of progabide. The results have been compared with those obtained in a control group of animals in which only bicuculline had been injected. In rats ages 7-14 days the treatment appears to be substantially ineffective in protecting animals against bicuculline seizures and their consequences, probably because of the substantial immaturity of the GABAergic system at birth and during the first days of life. At this age, repetitive administrations of progabide cause a protective anticonvulsant action more remarkable than the single injection, particularly when using the higher doses of the substance. In 15-28-day-old rats, the treatment significantly reduces the lethality from status epilepticus but does not substantially modify the incidence of seizures, their latency of appearance, or their evolution toward status epilepticus. As in younger animals, in these rats also pretreatment is more effective than treatment against bicuculline seizures, whatever dose of progabide is used. At this age, therefore, the anticonvulsant properties of progabide appear to be more remarkable than in the previous age, probably because of a higher level of development of the GABAergic system, according to biochemical data on the GABAergic system ontogenesis.